Matt Hancock back at Covid inquiry for probe into pandemic impact on care homes
Mr Hancock, who resigned from government in 2021 after admitting breaking social distancing guidance by having an affair with a colleague, has given evidence to the inquiry multiple times.
He will return on Wednesday for a full-day session to face questions specifically about the adult social care sector.
In a previous appearance before the inquiry he admitted the so-called protective ring he said had been put around care homes early in the pandemic was not an unbroken one and insisted he understands the strength of feeling people have on the issue.
At a Downing Street press conference on May 15 2020, Mr Hancock said: 'Right from the start, we've tried to throw a protective ring around our care homes.'
Bereaved families have previously branded this phrase a 'sickening lie' and a 'joke'.
When the pandemic hit in early 2020, hospital patients were rapidly discharged into care homes in a bid to free up beds and prevent the NHS from becoming overwhelmed.
However, there was no policy in place requiring patients to be tested before admission, or for asymptomatic patients to isolate, until mid-April.
This was despite growing awareness of the risks of people without Covid-19 symptoms being able to spread the virus.
A lawyer for the families from the Covid-19 Bereaved Families for Justice (CBFFJ) campaign group described Mr Hancock's appearance as a 'seminal moment of the Covid inquiry that many of our clients have been waiting for'.
Nicola Brook, from Broudie Jackson Canter which represents more than 7,000 families from CBFFJ, said: 'While Mr Hancock has given evidence to the inquiry before, this is the first time that he has been called early in a module, meaning he won't be able to simply respond to others' evidence.
'I only hope that he tells the truth about what he knew about the decision to discharge Covid-infected patients into care homes, which was the biggest scandal of the whole pandemic. Only then will our clients be able to get some form of closure.'
From Monday, module six of the inquiry will look at the effect the pandemic had on both the publicly and privately funded adult social care sector across the UK.
Among the issues to be examined will be decisions made by the UK Government and devolved administrations on moving people from hospitals into adult care and residential homes in the early stages of the pandemic.
The module will also consider how the pandemic was managed in care and residential homes, including infection prevention and control measures, testing for the virus, the availability and adequacy of personal protective equipment (PPE), and the restrictions on access to such locations by healthcare professionals and loved ones.
Caroline Abrahams, charity director at Age UK, said many older people in care homes 'had a truly terrible time during the pandemic'.
She added: 'Those older people who survived and are still with us, and their families, have waited a long time for the pandemic inquiry to focus on their experiences but now their turn has finally come, so it's a big moment for them and for the inquiry too.'
The CBFFJ group has written to inquiry chairwoman, Baroness Heather Hallett, to express their concern at some 'key decision-makers' not expected to be called in this module, including former prime minister Boris Johnson.
They said: 'Without those who were responsible for critical policies like discharging untested hospital patients into care homes, the inquiry cannot deliver a full or credible account of what happened.'
They insisted the module must be 'a turning point' rather than 'an afterthought'.
'What happened in the care sector during the pandemic is a national scar. To fail to learn the right lessons now would compound the injustice and place future lives at risk,' they added.
Members of bereaved groups from across the UK are due to give evidence on Tuesday, while representatives of the National Care Forum and Royal College of Nursing will give evidence on Thursday.
Public hearings for the care sector module are expected to run until the end of July.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
ITV News
42 minutes ago
- ITV News
‘Life-changing' drug for teenager who lost mother, aunt and uncle to condition
A teenager who lost her mother, aunt and uncle to a genetic condition has become the first person in Europe to receive a 'life-changing' drug after it was approved for use on the NHS. Mary Catchpole, 19, suffers from activated PI3-Kinase delta syndrome (APDS), a rare inherited disorder that leaves people with a significantly weakened immune system. Patients with APDS are vulnerable to repeated infections and face a lifetime of antibiotics and invasive procedures to try and keep them well. Miss Catchpole's mother's side of the family has been badly affected by APDS – her mother Sarah died aged 43 in 2018, while her aunt Helen died aged 12, her uncle Edward when he was 39 and her grandmother Mary when she was 48. Now, thanks to researchers in Cambridge who identified APDS, Miss Catchpole has received a new drug to treat it at Addenbrooke's Hospital in Cambridge. The medicine, called leniolisib (Joenja), is the first ever targeted treatment for APDS and is a simple tablet taken twice a day. Miss Catchpole is a teaching assistant who lives in Great Yarmouth with her father Jimmy, 64, and brother Joe, 20, who does not have the condition. She told the PA news agency: 'I was diagnosed with APDS aged seven and it's had a big effect on my life. 'I had lots of cannulas when I was younger and lots of hospital trips. 'I had a permanent line in the side of my body when I was younger which they put medicine in regularly at the hospital. 'I wasn't allowed to do very much physical activity so I had to sit out a lot in PE at school. 'I used to be called an attention-seeker because obviously it was hidden, so no-one really believed me. 'It also stopped me from doing a lot of my dancing, which I've always loved to do. So it has been hard.' Miss Catchpole said taking the new drug is 'life-changing' as it means she can leave behind huge amounts of medication. She added: 'I feel really blessed because it's so simple to do and it doesn't take up very much time, whereas for the medication, it just takes such a long time to do. 'So it's really a blessing, but it's also obviously bittersweet because my late family members never got the chance to have it.' APDS was identified by Cambridge researchers in 2013, with Miss Catchpole's family playing a key role in its discovery. Her mother and uncle were Addenbrooke's patients and were offered DNA sequencing to see if there was a genetic cause for their immunodeficiency. Researchers identified a change in their genes that increased activity of an enzyme called PI3-Kinase delta – meaning this enzyme is effectively 'switched on' all the time. This prevents immune cells from fighting infection and leads to an abnormal immune function. The new drug works by inhibiting the enzyme, effectively normalising the immune system. Now, Miss Catchpole says she can look to the future with optimism and is excited to lead a normal life. 'I really want to become a dance teacher,' she said. 'I absolutely love my current job as a teaching assistant but I'd also like to go on some adventures as well. 'I've always felt different so it will be nice to feel like I belong. 'When I had sleepovers when I was younger and had to take all my medication with me, I didn't feel like a normal child. 'To be able to feel normal going about my day-to-day life is going to be really nice.' Until now, the only treatments for APDS patients were antibiotics for infections, immunoglobulin replacement therapy to prevent infections and organ damage, and a bone marrow or stem cell transplant. Dr Anita Chandra, consultant immunologist at Addenbrooke's and affiliated assistant professor at the University of Cambridge, said: 'It is incredible to go from the discovery of a new disease in Cambridge to a treatment being approved and offered on the NHS within the space of 12 years. 'This new drug will make a huge difference to people living with APDS.' Professor Sergey Nejentsev, from the University of Cambridge who led the research that discovered APDS, said: 'As soon as we understood the cause of APDS, we immediately realised that certain drugs could be used to inhibit the enzyme that is activated in these patients. 'Leniolisib does precisely that. I am delighted that we finally have a treatment which will change the lives of APDS patients.' Professor James Palmer, NHS England's medical director for specialised commissioning, said: 'We're delighted to see Mary become the first patient in Europe to receive this first ever targeted and approved therapy for a rare condition identified just over a decade ago – in Cambridge no less. 'This treatment could be life-changing for those affected by this debilitating genetic disorder, and this important step forward is another example of the NHS's commitment to offering access to innovative medicines for those living with rare conditions.' Experts believe the drug will work long-term in patients as long as they keep taking the tablets. Researchers are now looking at the potential for leniolisib to work on other, more common immune conditions. Patients eligible for leniolisib can be referred to Addenbrooke's for specialist review and care. Between 40 to 50 people in England are known to have APDS. The list price for leniolisib is £352,000 per person per year but the company Pharming has agreed a discount for the NHS. The team that discovered APDS included researchers from the University of Cambridge, Babraham Institute, Medical Research Council (MRC) Laboratory for Molecular Biology, and Addenbrooke's, with funding from Wellcome and the National Institute for Health and Care Research (NIHR).
BBC News
44 minutes ago
- BBC News
How is your NHS hospital doing on waiting times?
Doctors and patient groups warn that the NHS in England is facing an uphill struggle on the government's number one NHS priority – improving hospital waiting are concerned about the lack of progress towards hitting the 18-week waiting time target, one of Labour's key election pledges. It has not been met since the election, the proportion of patients waiting less than 18 weeks has improved, but by less than a percentage an analysis of hospital trusts by BBC Verify found over a third are seeing a smaller share of patients within 18 weeks since the NHS improvement plan was announced in the government said it was premature to suggest progress was too slow as the NHS had only started to push forward with the government's improvement plan in April. Before that, it had focussed on other priorities, including tackling the very longest waits. It said the fact waiting times had continued to improve even during winter - the first time this had happened for 10 years - was in an interview with the BBC, Health Secretary Wes Streeting said progress would go "further and faster" in the coming years, helped by the extra money being invested and the 10-year NHS plan, due to be published next said lots had been achieved so far, including millions more appointments being carried out and the total number of patients on the waiting list dropping to below 7.4 million, its lowest level for two the 18-week target, he acknowledged there was "much more to do", before adding: "There's a big challenge here. Are we going to meet it? Absolutely. We are not going to let people down."The government has promised to hit the target by March 2029, which requires 92% of patients to be seen within 18 January, every hospital trust was given their own individual performance targets to meet by March 2026 as the first step in achieving that Verify is launching an interactive tool, which we will update when there is new data, so you can find out how well your local NHS services are doing. We have included NHS trusts in England that had at least 5,000 cases waiting in November. 'I've forgotten what it is like to not be in pain' John Winnik does not know when he will get treatment for a problem with his grandfather from West Yorkshire, who has arthritis, has been on an NHS waiting list for nine months so far - much longer than the 18 weeks the health service says should be the 73-year-old paid privately to go to Lithuania for a right hip replacement last year, having spent more than a year on the NHS waiting also having injections in his left hip, which will eventually need replacing."I'm living in constant pain," said Mr Winnik, a self-employed consultant in the glass lamination industry. "I've forgotten what it is like to not be in pain, to be honest. I haven't played golf for two years and if I do five minutes of gardening, I'm shattered." Royal College of Surgeons of England president Tim Mitchell said: "The NHS is changing course, but the sails still lack wind."Progress is being made in some parts of the country, but it's too slow to meet the government's ambition of hitting the 18-week target by the end of this parliament."Delayed operations mean patients left waiting in pain, with their condition potentially deteriorating."He said the extra money being put into the NHS in the coming years would help, but "serious underinvestment" in infrastructure like operating theatres over the years is hampering Alsina, chief executive of the patient group Versus Arthritis, also has doubts, saying there was scepticism about whether the rapid progress needed could be she added: "It is impossible to overstate the personal, physical and mental toll of being stuck on a waiting list in daily pain, sometimes for years."There's also a wider impact on society, with many people on waiting lists having to drop out of work, despite wanting to stay in employment, and becoming increasingly reliant on others."The interim targets for March 2026 mean trusts either have to be seeing 60% of patients within 18 weeks of referral or improve on their November 2024 position by five percentage points - whichever is the NHS overall in England is expected to ensure 65% of patients do not wait longer than 18 weeks - currently less than 60% majority of trusts have already started making progress, however a BBC Verify analysis shows 50 - more than one third - are now further away from the target since November the trusts that have improved are taken into account the overall trend though is positive. A handful of trusts have already got to where they need to be by next March - as long as they can keep their waiting lists and West Lancashire Hospitals NHS Trust had more than 48,000 patients waiting less than 18 weeks so far for treatment, 64.2% of the total, in April. That is up from 58.7% in Sussex Healthcare NHS Trust also reached 60.1% in April, up from 54.9% in biggest target for improvement was set for The Princess Alexandra Hospital Trust in Harlow, according to our analysis. In November, 41.8% of its patients were waiting less than 18 weeks. By April, that had risen to about 48.8% - one of the biggest improvements in England so far. But it needs to rise further by more than 11 percentage points by next chief executive Thom Lafferty said they were "delighted" with their progress."We recognise the impact for patients who are waiting for care and we are enhancing integration and collaboration with our partners to ensure that patients can access the right care, in the right place, at the right time."Some trusts have a higher mountain to climb because their figures have dipped since and South Essex NHS Trust started out with 52.8% of patients waiting less than 18 weeks in November. But when the clock started in April, it had fallen to 47%.Two of its theatres at Basildon Hospital have been closed for work along with some of the trust's procedure rooms and it has had an increase in executive Matthew Hopkins said it was putting on extra clinics and had a new orthopaedic procedure room opening soon, adding: "We are confident we will improve our waiting times and improve patient experience."Others that have fallen despite requiring large improvements include the Robert Jones and Agnes Hunt Orthopaedic Hospital (RJAH) in Shropshire (down from 48.3% to 44.9%) and Countess of Chester, down from 49.6% to 47.1%.Cathy Chadwick, chief operating officer for Countess of Chester, said more clinics and investment in new technology would bring down waiting lists and the trust was confident of meeting the target by next March.A spokesman for RJAH said: "We have a clear ambition to hit the target of 60% by March 2026, and are confident that the plans we have put in place will enable us to do so." Targets in Scotland, Wales and Northern Ireland are different and the interim targets for next March set by the UK government do not the NHS is not meeting the waiting time targets in any Scotland aims for 90% of patients to be treated within 18 weeks of referral, in Wales the target is for 95% of patients to wait less than 26 Northern Ireland, 55% of patients should wait no longer than 13 weeks for day case or inpatient treatment. Interactive tool produced by Alli Shultes, Rebecca French, Ollie Lux Rigby, Chris Kay, Adam Allen, Avi Holden and Rebecca Wedge-Roberts What do you want BBC Verify to investigate?
Western Telegraph
an hour ago
- Western Telegraph
Ministers urged to act to protect hospice care for children
Together for Short Lives said hospices are being forced to rely on donations and funds raised from charity shops to prop up services as it called on ministers to increase ring-fenced NHS funding for children's hospices. A new poll of 30 hospices in England found almost nine in 10 (89%) expect their costs to exceed their income this financial year. The charity warned seriously ill children may die without accessing end-of-life care, symptom management and emotional and psychological support as a result. A report from the charity, seen by the PA news agency, states inflation, workforce shortages, and rising demand for care are stretching services to 'breaking point'. The report estimates costs for hospices have risen by 34% since 2021. However, statutory funding for children's hospices is still 'falling short' of what is needed, it adds. 'With reserves set to dwindle and deficits projected to grow, the future of children's hospice care is becoming increasingly unsustainable,' the authors wrote. The report also reveals disparities in funding across England, with neighbouring health authorities spending vastly different amounts on care. Together for Short Lives is urging ministers to increase ring-fenced NHS funding for children's hospices in England from £26 million in 2025/26 to £30 million by 2029/30. It said hospices have said that without this funding they would have to cut back on respite care and short breaks, emotional and psychological support, as well as end-of-life care. Nick Carroll, chief executive of Together for Short Lives, said: 'As ministers try to shift greater levels of healthcare from hospitals into communities, our amazing children's hospices are doing more than ever before to provide crucial support to seriously ill children and their families. 'But as their costs soar, they are having to rely even more on the generosity of the public amid patchy and unsustainable funding from the NHS. 'To expect the complex and often specialist healthcare these families need to be funded by charity shops and donations is wrong – we wouldn't accept this for other parts of our health and care system, so to add more uncertainty to families' lives when many simply don't know how long they have left with their children is unacceptable.' As well as providing end-of-life care, hospices also offer services including emergency support, symptom management and short breaks for respite. One parent described how she 'couldn't live without' the support of her local hospice. Laura McArthur, from Bristol, relies on the Jessie May hospice in the city for support in caring for her seven-year-old son Archie, who has cerebral palsy. But the future of the hospice remains 'unclear' after its charitable expenditure has risen sharply, and uncertainty around funding has forced it to draw on its reserve and rely on voluntary income, Together for Short Lives said. Ms McArthur said: 'Jessie May has known Archie since he was six months old. 'They have been there through it all. 'His needs are so complex, requiring around-the-clock care – at times it can be very difficult. 'Jessie May come and look after Archie so I can have a short break. 'As the years go on, caring for a disabled child is both physically and mentally exhausting. The truth is that I couldn't live without their support.' Mr Carroll added: 'As it finalises its NHS 10-year plan, the UK Government must put in place a long-term, sustainable funding model for children's palliative care in England. 'Immediately, ministers should act to protect and maintain the NHS children's hospice grant and put it on a path to £30 million by 2030. 'Only by doing so can the Government make sure lifeline services are not cut for seriously ill children, which could deny many the choice of accessing end of life care from a children's hospice.' A Department of Health and Social Care spokesperson said: 'The Government recognises the incredible work that children and young people's hospices do across the country. 'We are investing £100 million to improve hospices facilities, and a further £26 million specifically for children's hospices this year, the biggest investment in hospices in a generation. 'We are also working to make sure the palliative and end of life care sector is sustainable in the long-term and are determined to shift more healthcare out of hospitals and into the community through our Plan for Change.'
